丙型肝炎临床仪表盘：改善肝脏专科护理的可及性与质量。
Hepatitis C Clinical Dashboards: Improving Liver Specialty Care Access and Quality.
作者信息
Lau Marcos, Beste Lauren A, Kryskalla Jennifer, Rongey Catherine
机构信息
is an academic detailing data manager, Department of Pharmacy, VHA Pharmacy Benefits Management, Los Angeles, California. is a staff physician, Department of Medicine, Puget Sound VAMC and University of Washington School of Medicine, Seattle, Washington. is the VISN 22 pharmacoeconomist and pharmacy data analyst, Desert Pacific VISN in Long Beach, California. is the Viral Hepatitis National Public Health Clinical Lead, San Francisco VAMC, University of California San Francisco and an assistant professor at the University of California, San Francisco School of Medicine.
出版信息
Fed Pract. 2015 Feb;32(Suppl 2):32S-36S.
Abstract
Clinical dashboards can improve the health management of the HCV population within the VHA by empowering health care practitioners to deliver wide and effective HCV care.
摘要
临床仪表盘可以通过使医疗从业者能够提供广泛且有效的丙型肝炎病毒（HCV）护理，来改善退伍军人健康管理局（VHA）内HCV患者群体的健康管理。
相似文献
1
Hepatitis C Clinical Dashboards: Improving Liver Specialty Care Access and Quality.丙型肝炎临床仪表盘：改善肝脏专科护理的可及性与质量。
Fed Pract. 2015 Feb;32(Suppl 2):32S-36S.
2
Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.直接作用抗病毒治疗在退伍军人管理局治疗初治慢性 HCV 基因型 1 感染患者中的成本效益。
Clin Gastroenterol Hepatol. 2013 Nov;11(11):1503-10. doi: 10.1016/j.cgh.2013.05.014. Epub 2013 May 22.
3
Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.如何让研究人员、从业者、政策制定者和受影响的社区共同努力，改善吸毒人群获得丙型肝炎治疗的途径，为这些人群确定优先事项和推荐行动。
Int J Drug Policy. 2019 Apr;66:87-93. doi: 10.1016/j.drugpo.2019.01.012. Epub 2019 Feb 8.
4
Dashboards for improving patient care: review of the literature.用于改善患者护理的仪表盘：文献综述
Int J Med Inform. 2015 Feb;84(2):87-100. doi: 10.1016/j.ijmedinf.2014.10.001. Epub 2014 Oct 12.
5
Increasing access for veterans with hepatitis C by enhancing use of clinical pharmacy specialists.通过加强临床药学专家的使用，增加丙型肝炎退伍军人的获得途径。
J Am Pharm Assoc (2003). 2019 May-Jun;59(3):398-402. doi: 10.1016/j.japh.2019.01.018. Epub 2019 Mar 8.
6
Developing a hospital-wide quality and safety dashboard: a qualitative research study.开发全院范围的质量和安全仪表板：一项定性研究。
BMJ Qual Saf. 2018 Dec;27(12):1000-1007. doi: 10.1136/bmjqs-2018-007784. Epub 2018 Jun 27.
7
8
Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care.前瞻性评估丙型肝炎病毒抗体快速诊断检测，提高获得医疗服务的工具。
Clin Microbiol Infect. 2016 May;22(5):459.e1-6. doi: 10.1016/j.cmi.2016.01.009. Epub 2016 Jan 22.
9
Specialty care and education associated with greater disease-specific knowledge but not satisfaction with care for chronic hepatitis C.专业护理和教育与更专业的疾病知识相关，但与慢性丙型肝炎的护理满意度无关。
Aliment Pharmacol Ther. 2009 Aug;30(3):275-82. doi: 10.1111/j.1365-2036.2009.04036.x. Epub 2009 May 6.
10
A Home Care Practice Scenario Using Clinical Dashboards.一个使用临床仪表盘的家庭护理实践场景。
Home Healthc Now. 2017 Feb;35(2):83-95. doi: 10.1097/NHH.0000000000000500.
引用本文的文献
1
Review article: current and emerging therapies for the management of cirrhosis and its complications.综述文章：肝硬化及其并发症管理的当前及新兴疗法
Aliment Pharmacol Ther. 2022 May;55(9):1099-1115. doi: 10.1111/apt.16831. Epub 2022 Mar 2.
2
The Future of Quality Improvement for Cirrhosis.肝硬化质量改进的未来。
Liver Transpl. 2021 Oct;27(10):1479-1489. doi: 10.1002/lt.26079. Epub 2021 Jul 31.
3
Innovations in Hepatitis C Screening and Treatment.丙型肝炎的筛查和治疗创新。
Hepatol Commun. 2020 Dec 7;5(3):371-386. doi: 10.1002/hep4.1646. eCollection 2021 Mar.
本文引用的文献
1
Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs.美国退伍军人事务部慢性丙型肝炎病毒感染的患病率及治疗情况
Epidemiol Rev. 2015;37:131-43. doi: 10.1093/epirev/mxu002. Epub 2015 Jan 19.
2
Despite substantial progress In EHR adoption, health information exchange and patient engagement remain low in office settings.尽管电子健康记录（EHR）的采用取得了实质性进展，但在医疗机构中，健康信息交换和患者参与度仍然较低。
Health Aff (Millwood). 2014 Sep;33(9):1672-9. doi: 10.1377/hlthaff.2014.0445. Epub 2014 Aug 7.
3
Impact of rural residence and health system structure on quality of liver care.农村居住情况和卫生系统结构对肝脏护理质量的影响。
PLoS One. 2013 Dec 26;8(12):e84826. doi: 10.1371/journal.pone.0084826. eCollection 2013.
4
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.索磷布韦和来迪派韦固定剂量复方与利巴韦林联合或不联合用于初治和经治的基因 1 型丙型肝炎病毒感染患者（LONESTAR）：一项开放标签、随机、2 期临床试验。
Lancet. 2014 Feb 8;383(9916):515-23. doi: 10.1016/S0140-6736(13)62121-2. Epub 2013 Nov 5.
5
Best practices: The electronic medical record is an invaluable clinical tool: let's start using it.最佳实践：电子病历是一种非常有价值的临床工具：让我们开始使用它。
Psychiatr Serv. 2013 Oct;64(10):946-9. doi: 10.1176/appi.ps.201300272.
6
Usability and accessibility in consumer health informatics current trends and future challenges.消费者健康信息学中的可用性和可访问性：当前趋势和未来挑战。
Am J Prev Med. 2011 May;40(5 Suppl 2):S187-97. doi: 10.1016/j.amepre.2011.01.009.
7
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.慢性丙型肝炎病毒感染患者中 HCC 和肝硬化的患病率不断增加。
Gastroenterology. 2011 Apr;140(4):1182-1188.e1. doi: 10.1053/j.gastro.2010.12.032. Epub 2010 Dec 22.
8
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.FIB-4：丙型肝炎病毒感染中一种廉价且准确的纤维化标志物。与肝活检及FibroTest的比较
Hepatology. 2007 Jul;46(1):32-6. doi: 10.1002/hep.21669.
9
The model for end-stage liver disease (MELD).终末期肝病模型（MELD）
Hepatology. 2007 Mar;45(3):797-805. doi: 10.1002/hep.21563.
10
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers.美国退伍军人医疗中心使用者中丙型肝炎感染率升高。
Hepatology. 2005 Jan;41(1):88-96. doi: 10.1002/hep.20502.
Zotero 插件